Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

Valiant Laboratories Other Announcement

Valiant Laboratories Limited is exploring potential restructuring options across its holding and subsidiary entities. The board aims to achieve strategic synergies and unlock long-term shareholder value.

Source

NSE filing, NSE: VALIANTLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Valiant Laboratories Ltd: key numbers

Share price
₹125.82
Market cap
₹683.4 Cr
Revenue (annual)
₹237.5 Cr
Net profit (annual)
₹-3.27 Cr
P/E (TTM)
42.7×Sector 46.1×
Promoter holding
74.94%+0.00% QoQ
FII holding
0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Valiant Laboratories Ltd

All →

Other other announcement announcements

All →